Norway Savings Bank purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the first quarter, Holdings Channel.com reports. The institutional investor purchased 1,448 shares of the semiconductor company’s stock, valued at approximately $574,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Sankala Group LLC bought a new position in Synopsys in the 4th quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys during the 4th quarter worth about $28,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $32,000. Finally, Osbon Capital Management LLC acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $34,000. 85.47% of the stock is currently owned by institutional investors.
Insider Transactions at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the stock. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research note on Wednesday, May 27th. KeyCorp restated an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a “buy” rating in a research note on Wednesday, February 25th. Robert W. Baird set a $558.00 price target on Synopsys in a research report on Thursday, May 28th. Finally, Wells Fargo & Company boosted their price objective on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $570.06.
Read Our Latest Stock Analysis on SNPS
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Piper Sandler upgraded Synopsys to Overweight from Neutral and raised its price target to $550 from $450, citing improving prospects for its intellectual property business as Intel’s foundry momentum builds and Apple-related opportunities expand. Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Positive Sentiment: Analysts and commentators continue to highlight Synopsys’ recurring revenue model, expanding AI-driven design tools, and IP licensing as a strong way to participate in the AI semiconductor buildout. Synopsys vs. Applied Digital: Which AI Stock Has an Edge Right Now?
- Positive Sentiment: New coverage argues Synopsys’ AI-driven Multiphysics Fusion platform and the Ansys integration could deepen its role in chip design workflows and support a higher long-term earnings base. Does Synopsys’ AI-Driven Multiphysics Fusion Platform Redefine the Bull Case for Synopsys (SNPS)?
- Neutral Sentiment: Several pieces note that Synopsys has pulled back over the past month, which has made valuation look more reasonable to some investors, but these articles are mainly framing the stock’s setup rather than pointing to a new catalyst. Synopsys (SNPS) Stock After Recent Pullback Is The Valuation Now More Reasonable
- Neutral Sentiment: Synopsys co-founder Alberto Sangiovanni-Vincentelli being shortlisted for a lifetime achievement award is a positive reputational headline, but it is unlikely to move the stock on its own. Synopsys (SNPS) Co Founder Shortlisted For Lifetime Achievement Award
- Negative Sentiment: No major negative company-specific news was reported in these articles; the main headwind remains that Synopsys has recently cooled off from prior highs, leaving investors focused on whether growth can justify the valuation. Synopsys: Ansys, AI, And The Case For A Higher Earnings Base
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
